Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
Phase 4
Not yet recruiting
- Conditions
- Lactating Mother
- Interventions
- Drug: Vyleesi (Bremelanotide Injection)
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Cosette Pharmaceuticals, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06867835
© Copyright 2025. All Rights Reserved by MedPath